ZEN BIO INC has a total of 33 patent applications. Its first patent ever was published in 1998. It filed its patents most often in United States, Taiwan and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are CELL CURE NEUROSCIENCES LTD, ANTEROGEN CO LTD and LINEAGE CELL THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | Taiwan | 5 | |
#3 | Canada | 4 | |
#4 | China | 4 | |
#5 | Japan | 4 | |
#6 | WIPO (World Intellectual Property Organization) | 4 | |
#7 | EPO (European Patent Office) | 3 | |
#8 | Australia | 2 | |
#9 | Hong Kong | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Medical technology | |
#4 | Organic fine chemistry | |
#5 | Measurement | |
#6 | Agriculture |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Microorganisms | |
#3 | Therapeutic chemical compounds | |
#4 | Object sterilising | |
#5 | Implantable devices | |
#6 | Specific use of cosmetics | |
#7 | Analysing materials | |
#8 | Animal care |
# | Name | Total Patents |
---|---|---|
#1 | Wilkison William O | 15 |
#2 | Pieraccini Peter | 8 |
#3 | Halvorsen Yuan-Di C | 7 |
#4 | Halvorsen Yuan-Di Chang | 6 |
#5 | Buehrer Benjamin | 5 |
#6 | Gimble Jeffrey M | 5 |
#7 | Halvorson Yuan-Di Chang | 4 |
#8 | Lea-Currie Yolanda Renee | 3 |
#9 | Ludlow John W | 3 |
#10 | Halvorsen Yua-Di Chang | 3 |
Publication | Filing date | Title |
---|---|---|
WO2020180311A1 | Plant-based exosome compositions and use thereof for rejuvenating skin | |
WO2019139762A1 | Exosome compositions and use thereof for joint disorders and diseases | |
EP3328403A1 | Exosome compositions and use thereof for soft tissue repair | |
WO03006009A1 | Compositions for reducing or preventing cellulite in mammalian skin | |
AU3836301A | Compositions for preventing cellulite in mammalian skin | |
TW200712208A | Use of adipose tissue-derived stromal cells for chondrocyte differentiation and cartilage repair | |
US6100047A | Modulation of the sulfonylurea receptor and calcium in adipocytes for treatment of obesity/diabetes | |
US6153432A | Methods for the differentiation of human preadipocytes into adipocytes | |
WO9928444A1 | Differentiation of adipose stromal cells into osteoblasts and uses thereof |